Clinical Trial Update: 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for 18F-fluciclovine (FACBC) PET/CT in men with rising PSA after initial prostate cancer treatment; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Axumin (fluciclovine F-18)

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-01-28